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ABSTRACT 
Pain is the predominant symptom for people with inflammatory arthritis (IA) and osteoarthritis 
(OA) mandating the development of evidence-based recommendations for the health 
professional’s approach to pain management. A multidisciplinary task force including 
professionals and patient representatives conducted a systematic literature review of 
systematic reviews to evaluate evidence regarding effects on pain of multiple treatment 
modalities. Overarching principles and recommendations regarding assessment and pain 
treatment were specified on the basis of reviewed evidence and expert opinion. From 2914 
review studies initially identified, 186 met inclusion criteria. The task force emphasized the 
importance for the health professional to adopt a patient-centered framework within a 
biopsychosocial perspective, to have sufficient knowledge of IA and OA pathogenesis, and to 
be able to differentiate localized and generalized pain. Treatment is guided by scientific 
evidence and the assessment of patient needs, preferences and priorities; pain 
characteristics; previous and ongoing pain treatments; inflammation and joint damage; and 
psychological and other pain-related factors. Pain treatment options typically include 
education complemented by physical activity and exercise, orthotics, psychological and 
social interventions, sleep hygiene education, weight management, pharmacological and 
joint-specific treatment options, or interdisciplinary pain management. Effects on pain were 
most uniformly positive for physical activity and exercise interventions, and for psychological 
interventions. Effects on pain for educational interventions, orthotics, weight management, 
and multidisciplinary treatment were shown for particular disease groups. Underpinned by 
available systematic reviews and meta-analyses, these recommendations enable health 
professionals to provide knowledgeable pain management support for people with IA and 
OA. 
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INTRODUCTION 
Pain is the predominant symptom in the majority of people with inflammatory arthritis (IA) and 
osteoarthritis (OA), which both broadly contribute to the global burden of rheumatic and 
musculoskeletal conditions.[1-5] Knowledgeable pain management support can reduce pain, 
increase functioning and well-being, and reduce individual and societal costs.[6] Therefore, 
practitioners in all healthcare settings should have the knowledge and skills required to help 
people with IA and OA to better manage their pain. Rheumatology health professionals are 
ideally placed to provide comprehensive, evidence-based, and patient-centered care.[7] 
 Pain is a complex and multifaceted experience. Besides pathological processes such 
as inflammation and tissue damage, multiple individual factors influence pain, e.g., illness 
beliefs, mood, avoidance behavior, obesity, sleep disturbance, and the pattern of rest and 
activity throughout the day.[8-13] These factors are commonly mentioned in educational 
materials and are part of the pain management approach by health professionals in 
rheumatology.[9, 14, 15]  
Meta-analyses and randomized controlled trials (RCTs) have, for instance, been 
performed with respect to pharmacological pain treatment in OA,[16, 17] aerobic exercise in 
rheumatoid arthritis and OA,[18, 19] activity pacing in chronic pain,[20] and broad education 
and self-management approaches in rheumatic diseases.[15, 21] Evidence regarding pain 
management support in IA and OA ranges from RCTs to expert reports, but as yet the effect 
of pain management options on pain have not been studied in a comprehensive way for 
multiple pain modalities. The aim of this review was to evaluate the existing scientific 
evidence associated with the benefits of the health professional’s approach to pain 
management for people with IA and OA, and to use this evidence and expert opinion to 
provide recommendations that enable health professionals to provide knowledgeable pain 
management support. 
  
METHODS 
The standardized operating procedures for EULAR-endorsed recommendations were 
followed,[22] including a systematic literature review and definition of the strength of 
recommendations by a task force of experts. In the current article, the recommendations 
regarding management options mostly include advice with sufficient data-driven evidence, 
whereas the overarching principles and recommendations regarding assessment are based 
on expert opinion, because they could not be substantiated with evidence from systematic 
reviews. 
 
Task force 
The task force that included 18 members (16 from Europe and 2 from the USA) from 12 
countries consisted of patient representatives, nurses, physiotherapists, psychologists, 
rheumatologists, a general practitioner, an occupational therapist, a clinical epidemiologist, 
and a research fellow. The executive committee of the task force consisted of a convener 
(RG), methodologist (RC) and research fellow (CLO). During the first of two task force 
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meetings, the research questions, scope of the project, and pain management options were 
defined. 
 
Scope 
Definition of the scope and framing of questions addressing management options in 
systematic reviews helped the task force to achieve focused recommendations. This process 
was guided by PICO, which specifies the patient Population, Interventions, Comparator, and 
Outcomes of interest.[23] 
 The target users of the recommendations are health professionals in the field of 
rheumatology including rheumatologists. The target population for these recommendations 
are patients with OA and patients with the following types of IA: rheumatoid arthritis (RA), 
spondyloarthritis (SpA), and psoriatic arthritis (PsA). 
 It was decided that recommendations should cover core general pain management 
that virtually any health professional should be able to give including the appraisal of 
treatment options which require referral to specialized pain treatment. These options 
requiring referral included in the recommendations should be readily available to most 
healthcare practitioners. Moreover, it was decided to exclude general pharmacological and 
joint-specific medical and surgical treatments such as arthroplasty and glucocorticoid 
injections from the systematic literature review, because these are better covered by the 
existing EULAR task force recommendations for the management of IA and OA.[16, 17, 24-
29]  
 To restrict the systematic literature review to pain management strategies, the target 
outcome of our systematic review was pain. However, consistent with other expert 
groups,[30, 31] the task force unanimously endorsed that, besides pain, physical functioning 
(e.g., activity) and psychological functioning (e.g., emotional well-being and participation) are 
core domains of any management intervention in rheumatic care. This focus on pain as an 
outcome, but also the multiple management options that are reviewed and the broad group 
of patients to which this study is relevant, differentiates our study from studies with a more 
general focus on education in inflammatory arthritis,[21] or non-pharmacological 
management of osteoarthritis.[15]  
 
Systematic literature review 
The bibliographic databases Cochrane, Embase, PsycINFo, PubMed, Scopus, and Web of 
Science were searched with the name of one or more of the diseases of interest in the title 
and the word ‘pain’ and a word referring to a mode of intervention or care in the title, 
abstract, or key words (search date: October 19th, 2015). For efficiency in answering the 
broad question of the literature review and to benefit from the work that was done previously, 
the search was limited to systematic reviews, meta-analyses, (practice) guidelines, and 
recommendations. If no systematic reviews were available, we searched for RCTs. No time 
or language restrictions were applied in the initial search. Thus, included in the literature 
search were systematic reviews in one of the selected diseases (RA, SpA, PsA, OA) with 
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pain as an outcome measure. Excluded were studies involving general pharmacological and 
joint-specific medical and surgical treatment.  
 All abstracts were independently read and judged on their suitability for inclusion by 
two reviewers. Results were compared and, in case of discrepancy, discussed until 
consensus was reached. Excluded were duplicate articles, articles that were withdrawn, 
those not written in English, animal studies, conference abstracts, articles including (practice) 
guidelines or recommendations without a systematic review or meta-analysis included, 
previous versions of reviews and meta-analyses (e.g., Cochrane reviews), articles that did 
not have pain as a reported outcome measure or did not report outcomes for OA, RA, SpA or 
PsA, articles not reviewing the effect of one or multiple modes of intervention or care, and 
articles that only reviewed the effects of pharmacological treatments, surgical treatments, 
alternative medicine, herbs, or nutraceuticals. Reference lists of the selected articles were 
hand-searched for additional relevant systematic reviews and meta-analyses. The detailed 
search keys and exclusion criteria are shown in online supplementary file 1. 
 
Evaluating the evidence 
The evidence for OA was divided into evidence for OA in general, OA of the knee, hip, or 
knee and hip, OA of the hand/wrist, and OA of the foot/ankle. The systematic reviews and 
meta-analyses commonly included a mean effect size for pain. For every treatment option 
and per disease subgroup, the effect found by the included articles was recorded and effect 
categories were distinguished: ‘positive effect’ (i.e. articles [unanimously] state positive 
effects of the treatment option on pain), ‘no effect’ (i.e., articles state the treatment option has 
neither positive nor negative effects), ‘unclear effect’ (i.e. articles state both no effects and 
positive effects), or a combination thereof meaning that articles were divided in their 
conclusions on the effect of the treatment option (e.g. some state unclear effects and others 
only positive effects). ‘Negative effect’ could have been a category, but none of the included 
studies stated harmful overall effects of the examined treatment options.  
 Our systematic review protocol was developed as a review of reviews including 
systematic reviews and meta-analyses of RCTs. Therefore, the Oxford center for evidence-
based ‘category of evidence’ for all recommendations was 1A (from meta-analysis or RCTs) 
or occasionally 1B (when only one RCT was available).[22] The Grades of Recommendation, 
Assessment, Development and Evaluation (GRADE) system was used to rate the overall 
quality of evidence of the reviews and meta-analyses.[32] Two assessors independently 
graded the quality of the available evidence as high, moderate, low, or very low. In case of 
discrepancy, the quality was discussed until consensus was reached.[33] ‘Strength of 
recommendation’ was determined for the recommendations. These scores vary from A 
(‘Category of evidence’ 1A: meta-analysis of randomized controlled trials) to D (‘Category of 
evidence’ 4 from expert committee reports or opinions and/or clinical experience of respected 
authorities or extrapolated recommendation from ‘category of evidence’ 2 or 3 from non-
randomized experimental, correlation, or descriptive studies).[22] 
 
Developing recommendations 
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During the second and last task force meeting, the results of the systematic literature were 
presented and discussed, and the wording of recommendations was started. Treatment 
recommendations were supported by findings in the systematic literature review. 
Overarching principles and assessment recommendations were mostly based on expert 
opinion in the task force. After this meeting, the wording was finished through e-mail, and 
each task force member indicated the ‘level of agreement’ on a numerical rating scale 
ranging from 0 (completely disagree) to 10 (completely agree). 
 
RESULTS 
Figure 1 shows a flow chart of the systematic literature review. The 2914 selected titles 
reduced to 214 after exclusion of duplicates and check of exclusion criteria. Full texts of 17 
articles could not be obtained. Two assessors read 197 articles in full-text. Another 13 
articles were excluded for being a narrative (non-systematic) review (3x), guideline without 
systematic review (1x), or duplicate (2x), not having pain as an outcome (4x), or treatment 
effects on pain as an aim (2x), or involving only results of pharmacological treatment (1x). 
Two additional meta-analyses were included after scanning the reference list of the selected 
articles. In total, 186 systematic reviews and meta-analyses were included and their content 
was assessed for the following information: population, types of intervention, effects, and 
level of quality. This information is provided in online supplementary files 2, 3, and 4 for all 
included studies. 
 
Evaluation of effects on pain (systematic literature review)  
No studies were found that systematically reviewed effects on pain for PsA. Moreover, it was 
found that of the included treatment options, sleep interventions and most assistive devices 
were not evaluated for their effect on pain in systematic reviews. Studies were 
heterogeneous with respect to intervention and comparator conditions. For example, 
comparisons of exercise included land-based vs. water-based, strengthening vs. aerobic, 
group vs. individual, supervised vs. home-based, multimodal vs. unimodal, progressive vs. 
non-progressive, and one or various exercises vs. standard care, sham, or medication. The 
reviewed studies, direction of effects, and level of quality are shown in table 1 and table 2 for 
the treatment modalities that were included in the recommendations and in table 3 for 
miscellaneous treatment modalities. 
 
Education and self-management 
The reviewed review studies on education and self-management programs generally 
concluded that available studies showed ‘positive effects’ (n=8) or showed both ‘no effects’ 
and ‘positive effects’ (n=14), but for SpA and OA of the hand/wrist single meta-analyses 
observed ‘no effect’ on pain (table 1). 
 
Physical activity and exercise 
Of all treatment options, the effects of physical exercise have been studied most extensively 
(table 2). For general exercise, aerobic exercise, and strength and resistance training, the 
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quality of studies was low to moderate and effects on pain were mostly ‘positive’ in IA and 
OA, with some reviews observing ‘no effects’. For Tai Chi, yoga, qigong, and whole body 
vibration, the quality of studies was low to very low, and it was unclear whether there were 
positive effects on pain. Table 2 can be used as a guide for choosing an appropriate 
intervention; for instance, strength and resistance training is more relevant and more 
extensively studied for OA of the knee than for other conditions. Reviews do not answer the 
question whether high-intensity exercise is as safe as low-intensity exercise, which is an 
ongoing issue of debate.[34, 35] 
 
Orthotics 
In mostly low quality studies, ‘positive effects’ of orthotics on pain have been consistently 
observed for orthopedic shoes in RA and OA of the knee, splints in OA of the hand, and 
sleeves and elastic bandages in OA of the knee and less consistently for other orthotics 
(table 1). Except for use of a cane,[16] no systematic reviews evaluated daily living aids such 
as a tin-opener or assistive devices using pain as an outcome. Although several orthotics 
can be recommended based on positive effects on pain, there is not enough evidence to give 
recommendations regarding design or materials. 
 
Psychological and social interventions 
In very low to moderate quality studies, effects of psychological interventions (e.g., cognitive-
behavioral therapy (CBT), mindfulness-based interventions, stress management training) on 
pain as summarized in reviews were ‘positive’ with the exception of reviews showing ‘no 
effect’ on pain of CBT in SpA and biofeedback in OA (table 1).  
 
Weight management 
In very low to moderate quality studies, effects of weight management have been frequently 
reviewed for OA of the knee; ‘no effects’ and ‘positive effects’ were observed. For RA and 
SpA, ‘positive effects’ were observed in three reviews (table 1). 
 
Sleep interventions 
It has been proposed that sleep disturbance should be systematically assessed and 
managed in patients with IA and OA.[13, 36-38] Our systematic review did not extract 
systematic reviews that evaluated effects of sleep interventions on pain in OA or IA, but 
randomized trials examined the effects of cognitive-behavioral therapy (CBT) for insomnia in 
OA. CBT was observed to improve sleep and pain in one study.[39] In another study both 
CBT and a placebo condition resulted in improved sleep and comparable reductions of pain 
over 6 months, but the CBT group had significantly greater reductions in wake after sleep 
onset, which predicted subsequent decreases in clinical pain.[40] Outside the field of 
rheumatic diseases, meta-analyses support the effectiveness of behavioral, including self-
help, interventions on sleep outcomes.[41, 42] Face-to-face treatments of at least four 
sessions seem to be more effective than self-help interventions.[43] In meta-analyses, small 
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but significant effects of sleep interventions on pain have been observed in people with 
varied chronic medical conditions.[44, 45] 
  
Pharmacological treatment 
Pharmacological treatment is a core ingredient of pain management in IA and OA. It includes 
analgesics (e.g. paracetamol, codeine and other opiate-like drugs); oral or topical non-
steroidal anti-inflammatories (NSAIDs); intra-articular injections, e.g. with glucocorticoids; 
and occasionally also agents for neuropathic pain. The evidence for pharmacological pain 
treatment was not part of the current review but has been evaluated by other task forces.[16, 
17, 24-29, 46-50] In brief, previous task forces recommended paracetamol as first line 
treatment, with topical agents such as topical NSAIDs and capsaicin also recommended for 
specific joints, for patients with OA,[17, 26, 29] and consideration of intra-articular injections 
for specific joints in OA and IA.[17, 24-26, 28, 29] Existing EULAR recommendations should 
be consulted regarding the safe use of NSAIDs.[17, 26, 29, 46] 
 
Miscellaneous therapies 
Table 3 shows an overview of less commonly available therapies in rheumatologic clinical 
practice that were therefore not included in the recommendations. This overview is a quick 
guide to the appropriate meta-analyses if a patient asks for the effects of one of these 
treatment and skilled professionals are available. These therapies have especially been 
studied in OA of the knee with positive effects on pain of acupuncture and ‘balneotherapy 
and massage’ and less clear effects of “electrical” therapies. 
 
Psoriatic Arthritis 
Pain is as high or higher in PsA than in RA,[51] and patients have an educational need to 
manage their pain.[52] Nevertheless, none of the extracted studies reviewed the health 
professional’s approach in PsA for effects on pain. Given the lack of specific knowledge, the 
health professional may use pain treatment options in RA to guide pain treatment in PsA.  
 
Overarching principles (expert opinion) 
The task force defined overarching principles based on expert opinion (table 4).  
 First, patient-centered care was considered important. Care that is respectful of and 
responsive to individual patient preferences, needs and values, and ensures that patient 
values guide clinical decisions,[53] may improve adherence and persistence with 
treatment.[21, 54-57] Validation of the patient’s pain experience is considered a prerequisite 
for trust, communication and engagement in treatment.  
 Second, a biopsychosocial model of pain was recommended. Relationships between 
all factors of this model are recognized to be interactive and reciprocal with mutually 
influencing pathways similar to a hanging mobile toy in which movement of one part causes 
movement of other parts. The importance of the distinct factors differs between individuals. 
 Third, in order to achieve pain control, it is crucial to treat disease activity and to 
prevent tissue damage. To meet that aim the health professional should have basic 
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knowledge of IA and OA. Common treatment goals in rheumatic diseases are to optimize 
control of inflammation, decrease disease activity, improve function and well-being, and to 
reduce pain and other disease-related symptoms.[15-17, 21, 24-29] 
 Fourth, the ability to differentiate between types of pain helps the health professional 
to direct the optimal pain management strategy. Pain localized in a specific region of the 
body might be due to peripheral nociceptive input such as inflammation or damage. 
Generalized pain is more often non-specific with regard to pathological findings and can be 
due to a dysfunction in the regulation of pain pathways. Pain is commonly regarded as 
generalized or widespread when pain is present in both sides of the body, above and below 
the waist and in axial body regions. In IA, generalized pain may remain despite good 
inflammatory control. Such pain requires comprehensive pain management strategies.[58, 
59] 
 Not all health professionals may currently have the required knowledge and skills to 
apply these principles. For those health professionals who have identified that they require 
further education in this area, the overarching principles can be used to direct their learning. 
This may involve work-based supervision with another health professional or undertaking an 
educational course that addresses some or all of these principles. 
 
Recommendations (systematic literature review and expert opinion) 
Table 5 shows the recommendations. Proper assessment is a prerequisite for proper pain 
treatment. Recommendations 1 (assessment) and 2 (personalized treatment plan) were 
based on expert opinion in the task force. Treatment recommendations 3 to 10 were based 
on the systematic literature review summarizing effects on pain. Specific considerations 
regarding application of these treatment options (indicated with an asterisk in table 5) were 
based on expert opinion of the task force.  
 
Assessment 
The extent of assessment depends on many factors such as available time. A first step in 
ensuring that pain management is patient-centered, is to invite patients disclosing the impact 
of pain on their daily functioning, to assess their ideas and concerns regarding the cause of 
their pain and the perceived control over pain episodes, and to take account of their 
expectations and preferences for treatment. It is deemed important to establish the patient’s 
functional and valued life goals, i.e. what it is that they cannot currently do as well as they 
would wish to. Research shows that individuals differ widely in terms of management 
needs.[21, 54, 60, 61] 
 Second, assess pain severity using a numerical or visual analogue pain rating 
scale,[62] and the onset, duration, location and spread (pain manikin), quality, interference, 
triggers, and progression of pain. Furthermore, appraise the type of pain (localized or 
generalized) and whether referral is needed to a pain specialist to evaluate the type of pain, 
current treatment, or current medication (safe use, interactions with other medication, side 
effects). Generalized pain can be recognized in a clinical interview and by the use of a pain 
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manikin such as the Michigan body map.[63] Use validated questionnaires to assess the 
potential presence of neuropathic pain.[62, 64-66] 
 Third, assess ongoing pharmacological and non-pharmacological treatments, 
previous treatments tried and the effects and side effects of these treatments, patient beliefs 
about ability to control and overcome pain and its consequences, and willingness of the 
patient to engage in additional treatment if deemed necessary. 
 Fourth, assess current inflammation and joint damage as sources of pain following 
the most recent recommendations.[67, 68] In case of poorly controlled inflammation, optimize 
disease control or refer to a rheumatologist for treatment according to recommendations.[25, 
27, 48] In case of localized (nociceptive) pain relating to OA, consider (to refer to) joint 
specific treatments in line with recommendations.[16, 69] 
 Fifth, assess pain-related biological, psychological, and social factors that might need 
attention, specifically: 
- The nature and extent of disability: physical activity, mobility, activities of daily living, social 
participation, general physical fitness (aerobic capacity, muscle strength, endurance), pain-
related fear and avoidance of activities, balance of activities and rest (pacing). 
- Beliefs and emotions about pain and pain-related disability: the psychological response to 
pain and psychological vulnerability factors: psychological distress, psychiatric comorbidity, 
and cognitions such as catastrophizing (rumination, magnification, and helplessness),[70] 
fear of movement-related pain,[71] catastrophizing, and pain self-efficacy.[72] 
- Social factors related to pain and its consequences: the way family members or other 
significant other reacts to patient’s pain or pain-related disability, work, family and friends, 
economic problems, housing. 
- Sleep problems: The quantity and quality of sleep, including whether the patient feels 
refreshed upon waking, and sleep hygiene habits such as regular exercise during the day, 
stress management, noise, sleep timing, and avoidance of caffeine, nicotine, alcohol, and 
daytime napping.[73]  
- Presence of obesity.[74] 
- Other factors that might influence pain or pain management, such as dependence on 
tobacco, alcohol or drugs.[75] 
 
Treatment 
Tables 1 to 3 offer an overview of the number of the reviewed reviews and meta-analyses, 
the observed effects of specific treatments on pain, and the quality of evidence of the 
studies.  
 Through shared decision making, treatment is guided by the expressed needs of the 
patient, the health professional’s assessment, and evidence-based treatment options. A 
stepped-care approach is recommended including education and self-management support 
in step 1 (recommendation 3), one or more treatment options by a specialist if indicated in 
step 2 (recommendations 4 to 9), or multidisciplinary treatment in step 3 (recommendation 
10).  
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 The choice for a specific intervention, is not only determined by effects on pain but 
also by effects on functioning, social participation, and well-being. Moreover, evidence for 
effects of specific pain treatments differ for specific diseases. The ‘strength of 
recommendation’ for recommendations 3 to 10 (table 5) holds for specific diseases in which 
uniform positive effects on pain (excluding studies with ‘very low’ quality of evidence) were 
observed. 
- Education had a uniform positive effect on pain in OA (hip/knee, knee). 
- Physical activity and exercise showed uniform positive effects on pain for general exercise 
in SpA and OA (general, hip/knee, knee, foot/ankle), aerobic exercise in OA (general, knee), 
and strength and resistance training in OA (general, hip/knee, hip, knee). 
- Orthotics showed small but consistent positive effects on pain for orthopedic shoes in RA 
and OA of the knee, splints in OA of the hand, and knee orthoses (especially sleeves, elastic 
bandages) in OA of the knee.  
- Psychological and social interventions showed a uniform positive effect on pain for 
cognitive behavioral therapy in RA and OA (general), psychosocial and coping interventions 
in OA (general), biofeedback in RA, and relaxation interventions in OA (general, hip/knee). 
- There was no meta-analysis that evaluated effects of sleep interventions on pain in IA or 
OA, but small effects of sleep interventions on pain were observed in meta-analyses in 
people with varied chronic medical conditions. 
- Weight management showed a uniform positive effect on pain in RA, SpA and OA of the 
hip/knee. 
- Multidisciplinary treatment is cautiously recommended considering the absence of studies 
examining the added effect on pain of multidisciplinary treatment to monodisciplinary 
therapies and considering that meta-analyses on multimodal treatment did not observe 
effects on pain. 
 
DISCUSSION 
Results and conclusions derived from 186 systematic reviews and meta-analyses were 
reviewed to identify the evidence associated with the benefits of the health professional’s 
approach to pain management for people with IA and OA. Effects on pain were most 
uniformly positive for physical activity and exercise interventions, and for psychological 
interventions. Effects on pain for educational interventions, orthotics, weight management, 
and multidisciplinary treatment were shown for particular disease groups. Recommendations 
for patient-centered pain management were guided by this scientific evidence and by clinical 
expert opinion. 
 The task force unanimously endorsed that in rheumatic care, besides pain severity, 
physical functioning and psychological functioning are major outcomes of any management 
intervention by health professionals, in agreement with other expert groups.[30, 31] Although 
pain was selected as the target outcome, our systematic literature review also included 
interventions that were not aimed at alleviating pain, but –for instance– at increasing muscle 
strength, physical activity, or emotional functioning. Nevertheless, our study showed that 
many evaluations of treatment options––especially physical activity and psychological 
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interventions––showed a reduction of pain in most patient groups. This included treatment 
options in which pain reduction was not the primary goal.  
 Box 1 presents questions for the future research agenda. Our systematic review 
showed that there is ample evidence for specific pain treatment options in specific groups. 
Nevertheless, there are several omissions in our knowledge with respect to effects of pain 
management on pain, especially in PsA, sleep interventions, assistive devices, and 
multidisciplinary treatment. Moreover, it is inherent to the multifaceted nature of pain, the 
heterogeneity of the group of patients with IA and OA, and specific needs of individual 
patients that pain management options of choice will differ among patients. From a clinical 
point of view, a multimodal approach will likely result in the best outcome, but from a 
scientific point of view, it would be more fruitful to learn whether a single treatment option is 
able to bring about change in pain and other outcomes. Thus, a main challenge in future 
research is to examine in which patient subgroups each specific treatment option causes a 
reduction of pain. Moreover, most studies pertain to systematic interventions in groups, but 
the most frequent clinical intervention is patient-customized education and advice given 
during a consultation, handing a brochure, or offering information through the internet. The 
effects of these minimal interventions should be investigated as well.  
 As pain is the predominant symptom and burden in IA and OA,[1-5] clinical training of 
rheumatology health professionals in pain management is essential. To ensure patient-
centered pain management, health professionals need knowledge, confidence, 
communication skills, and skills to support patients to translate intentions into action plans, 
which should be part of educational programs.[76-78] It has been demonstrated that training 
of professionals helps to improve pain management of OA.[79] Health professionals can use 
the handout shown in figure 2 as a guide in their work, while the more detailed findings and 
recommendations can be used to fine-tune treatment. Further, knowledge and skills 
indicated in the overarching principles and recommendations, should be used when 
reviewing pain curricula in higher education and in postgraduate clinical education.[76] Within 
EULAR, the current recommendations can be included in the ‘EULAR online course for 
health professionals’ which comprises specific diseases such as RA and OA as well as 
broader modules: https://www.eular.org/edu_online_course_hpr.cfm. Finally, these 
recommendations will be disseminated through this publication, and through a lay summary 
of the recommendations that will be disseminated among national patient associations.  
 In conclusion, guided by expert opinion and partly underpinned by a considerable 
number of systematic reviews and meta-analyses, an expert group developed and launched 
the first set of recommendations that enable health professionals to provide knowledgeable 
and evidence-based pain management support for people with IA and OA. 
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Figure 1. Flow chart of the systematic literature review of systematic reviews 
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Figure 2. Handout with guide to pain management in inflammatory arthritis and osteoarthritis 
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Table 1. Overview of systematic reviews of randomized trials (evidence category 1A) regarding 
education, orthotics, psychological interventions, and weight management: treatment modality and 
disease, direction of effect, and the quality of the evidence according to GRADE (Grades of 
Recommendation, Assessment, Development and Evaluation) in patients with rheumatoid arthritis 
(RA), Spondyloarthritis (SpA), and osteoarthritis (OA). Diseases without a review were excluded from 
the table. 
Treatment modality 
    Disease 
        Specific treatment modality 
Number of 
reviews 
Direction of 
effect 
GRADE 
quality of 
evidence 
Education and self-management    
    RA 8 o / + ⊕⊕ 
    SpA 1 o ⊕⊕ 
    OA-general 6 o / + ⊕⊕⊕ 
    OA-hand/wrist 1 o ⊕ 
    OA-hip/knee 4 + ⊕⊕⊕ 
    OA-knee 4 + ⊕⊕⊕ 
Orthotics    
    RA    
        Orthotic gloves 2 o / + ⊕⊕ 
        Splints 5 o / + ⊕⊕ 
        Insoles 8 o / + ⊕⊕ 
        Orthopedic shoes 3 + ⊕⊕ 
        Padded hosiery 1 + ⊕ 
    OA-hand/wrist    
        Orthotic gloves 1 o ⊕ 
        Splints 8 + ⊕⊕ 
    OA hip    
        Insoles 1 + ⊕ 
    OA-knee    
        Braces 10 ? / + ⊕⊕ 
        Sleeves 1 + ⊕⊕ 
        Elastic bandages 2 + ⊕⊕ 
        Taping 3 ? / + ⊕⊕ 
        Orthoses in general 1 + ⊕⊕ 
        Insoles 15 ? / + ⊕⊕ 
        Orthopedic shoes 1 + ⊕⊕ 
        Cane 1 + ⊕⊕ 
Psychological interventions    
    RA    
        Cognitive behavioral therapy 7 + ⊕⊕⊕ 
        Biofeedback 1 + ⊕⊕ 
    SpA     
        Cognitive behavioral therapy 1 o ⊕ 
    OA-general    
        Cognitive-behavioral therapy 1 + ⊕⊕⊕ 
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        Psychosocial and coping interventions 1 + ⊕⊕⊕ 
        Relaxation techniques 1 + ⊕ 
    OA-hip/knee    
        Relaxation techniques 1 + ⊕ 
    OA-knee    
        Biofeedback 1 o ⊕ 
Weight management    
    RA 2 + ⊕⊕ 
    SpA 1 + ⊕ 
    OA-hip/knee 2 + ⊕⊕⊕ 
    OA-knee 10 o / + ⊕⊕⊕ 
Multimodal treatment     
    RA    
        Comprehensive occupational therapy 1 o ⊕⊕ 
    OA-hand/wrist     
        Multidisciplinary therapy 1 o ⊕⊕ 
    OA knee    
        Comprehensive physical therapy 1 o ⊕⊕⊕ 
Direction of effect: + positive, o no, - negative, ? unclear (effect equivocal), or a combination thereof 
meaning that different reviews reached different conclusions about the effect of the treatment. 
GRADE: High ⊕⊕⊕⊕, Moderate ⊕⊕⊕, Low ⊕⊕, Very low ⊕ 
References are shown in online supplementary file 2.  
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Table 2. Overview of systematic reviews of randomized trials (evidence category 1A) regarding 
‘physical activity and exercise’: treatment modality and disease, direction of effect, and the quality of 
the evidence according to GRADE (Grades of Recommendation, Assessment, Development and 
Evaluation) in patients with rheumatoid arthritis (RA), Spondyloarthritis (SpA), and osteoarthritis (OA). 
Diseases without a review were excluded from the table.  
Treatment modality 
    Disease 
Number of 
reviews 
Direction of 
effect 
GRADE 
quality of 
evidence 
General exercise    
    RA 5 o / + ⊕⊕ 
    SpA 6 + ⊕⊕ 
    OA-general 6 + ⊕⊕⊕ 
    OA-hand/wrist 4 o / + ⊕⊕ 
    OA-hip/knee 11 + ⊕⊕⊕ 
    OA-hip 11 o / + ⊕⊕ 
    OA-knee 18 + ⊕⊕⊕ 
    OA-foot/ankle 2 + ⊕⊕ 
Aerobic exercise    
    RA 3 o / + ⊕⊕ 
    OA-general 3 + ⊕⊕⊕ 
    OA-hip/knee 2 o / + ⊕⊕ 
    OA-hip 1 o ⊕ 
    OA-knee 9 + ⊕⊕⊕ 
Strength and resistance    
    RA 2 o / + ⊕⊕ 
    OA-general 3 + ⊕⊕⊕ 
    OA-hand/wrist 2 o / + ⊕⊕ 
    OA-hip/knee 4 + ⊕⊕⊕ 
    OA-hip 3 + ⊕⊕ 
    OA-knee 14 + ⊕⊕⊕ 
Tai Chi, yoga, qigong, whole body vibration    
    RA 3 ? / + ⊕ 
    OA-general 6 o / + ⊕ to ⊕⊕ 
    OA-hand/wrist 3 + ⊕ 
    OA-hip/knee 1 o / + ⊕⊕ 
    OA-knee 12 o / + ⊕ to ⊕⊕ 
Direction of effect:: + positive, o no, - negative, ? unclear (effect equivocal), or a combination thereof 
meaning that different reviews reached different conclusions about the effect of the treatment. 
GRADE: High ⊕⊕⊕⊕, Moderate ⊕⊕⊕, Low ⊕⊕, Very low to low ⊕ to ⊕⊕, Very low ⊕. (The 
combined ⊕ to ⊕⊕ grade is due to difference in quality between studies of different modalities). 
References are shown in online supplementary file 3.  
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Table 3. Review of reviews (evidence category 1A) regarding miscellaneous therapies: treatment 
modality and disease, direction of effect, and the quality of the evidence according to GRADE (Grades 
of Recommendation, Assessment, Development and Evaluation) in patients with rheumatoid arthritis 
(RA), Spondyloarthritis (SpA), and osteoarthritis (OA). Diseases without a review were excluded from 
the table.  
Treatment modality 
     Disease 
Number of 
reviews 
Direction of 
effect 
GRADE 
quality of 
evidence 
Acupuncture    
    RA 5 o / + ⊕⊕ 
    OA-general 4 o / + ⊕⊕ 
    OA-hand/wrist 3 o / + ⊕ 
    OA-hip/knee 2 + ⊕⊕ 
    OA-hip 1 o ⊕⊕ 
    OA-knee 16 + ⊕⊕⊕ 
Balneotherapy and massage    
    RA 3 o / + ⊕⊕ 
    SpA 2 o / + ⊕ 
    OA-general 5 o / + ⊕ to ⊕⊕ 
    OA-hand/wrist 3 + ⊕ 
    OA-hip/knee 2 o / + ⊕ 
    OA-knee 8 + ⊕⊕ 
Thermotherapy    
    RA 4 o / + ⊕⊕ 
    OA-general 1 o ⊕ 
    OA-hand/wrist 3 o / + ⊕⊕ 
    OA-knee 4 o / + ⊕⊕ 
    RA 3 + ⊕⊕ 
    OA-general 2 o / + ⊕⊕ 
    OA-hip/knee 2 ? / o ⊕⊕ 
    OA-knee 12 o / + 
⊕⊕ to 
⊕⊕⊕ 
Electromagnetic therapy    
    RA 2 o / + ⊕⊕ 
    OA-general 1 + ⊕⊕⊕ 
    OA-hip/knee 3 + ⊕⊕   
    OA-knee 18 ? / + 
⊕⊕ to 
⊕⊕⊕   
Laser therapy    
    RA 3 + ⊕⊕ 
    OA-general 2 o / + ⊕⊕ 
    OA-hand/wrist 4 o ⊕⊕ 
    OA-knee 7 o / + ⊕⊕⊕ 
Magnet therapy    
    OA-general 1 o / + ⊕⊕ 
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    OA-hand/wrist 2 o / + ⊕⊕ 
    OA-knee 2 o ⊕⊕ 
Manual therapy / joint mobilization    
    OA-hand/wrist 4 + ⊕⊕⊕ 
    OA-hip/knee 1 o / + ⊕⊕ 
    OA-hip 1 + ⊕⊕ 
    OA-knee 1 + ⊕⊕ 
Diverse    
    OA-general (healing, qigong, chiropractic) 1 o / + ⊕ 
    OA-hand/wrist (leeches, copper bracelets) 2 o / ? ⊕ 
Direction of effect:: + positive, o no, - negative, ? unclear (effect equivocal), or a combination thereof 
meaning that different reviews reached different conclusions about the effect of the treatment or that 
the direction of effects differed between treatment modalities such as between Transcutaneous 
Electrical Nerve Stimulation (TENS) and Pulsed electromagnetic field therapy (PEMF), which are both 
included in ‘electromagnetic therapy’. 
GRADE: High ⊕⊕⊕⊕, Moderate ⊕⊕⊕, Low to moderate ⊕⊕ to ⊕⊕⊕, Low ⊕⊕, Very low to low 
⊕ to ⊕⊕, Very low ⊕ (The combined grades are due to difference in quality between studies of 
different modalities such as balneotherapy versus massage studies) 
References are shown in online supplementary file 4.  
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Table 4. Overarching principles 
- The assessment and treatment process should be guided by a patient-centered framework.  
- The health professional should understand that (any type of) pain encompasses multiple and 
mutually interacting biological, psychological and social factors that include but are not limited to pain 
severity, peripheral (inflammation and joint damage) and central neurophysiological processes, 
physical (dis)ability, resilience and vulnerabilities (emotions, cognitions, behavior, lifestyle), social 
factors (work, support, facilities, economic), sleep quality, obesity, and other health risks (e.g., 
smoking, alcoholism). 
- The health professional should have basic knowledge of the pathology, treatment, and sequelae of 
inflammatory arthritis and osteoarthritis. 
- The health professional should be able to differentiate between localized and generalized pain and 
knows that these types of pain may coexist. 
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Table 5. EULAR recommendations for the health professionals’ approach to pain management in inflammatory arthritis 
and osteoarthritis 
 
Level of 
evidence 
Strength 
of recom-
mendation 
Level of 
agreement 
task force: 
Mean (SD) 
1. Assessment by the health professional should include the following 
aspects (the assessment is brief or extensive depending on factors such as 
available time, whether it is a first or regular consultation, and the needs of 
the patient): 
4 D 9.3 (0.8) 
- patient’s needs, preferences, and priorities regarding pain management 
 and important activities, values and goals in daily life. 
   
- patient’s pain characteristics including severity, type, spread, and quality.     
- previous and ongoing pain treatments and the perceived efficacy.    
- current inflammation and joint damage as sources of pain, and whether 
these are adequately treated. 
   
- pain-related factors that might need attention: a) the nature and extent of 
pain-related disability, b) beliefs and emotions about pain and pain-related 
disability, c) social influences related to pain and its consequences, d) sleep 
problems, and e) obesity. 
   
2. The patient should receive a personalized management plan with the aim 
of reducing pain and pain-related distress and improving pain-related 
function and participation in daily life. This plan is guided by shared decision 
making, the expressed needs of the patient, the health professional’s 
assessment, and evidence-based treatment options. A stepped-care 
approach may include, in step 1, education and self-management support 
(recommendation 3); in step 2, one or more treatment options by a specialist 
if indicated (recommendations 4 to 9); or, in step 3, multidisciplinary 
treatment (recommendation 10). 
4 D 9.0 (0.8) 
3. The patient should receive education. 1A A 9.7 (0.6) 
* All patients have easy access to 1) educational materials (such as 
brochures or links to online resources with encouragement to stay active, 
sleep hygiene guidelines, and so on), 2) psychoeducation by the health 
professional, and 3) online or face-to-face self-management interventions  
   
4. If indicated, the patient should receive physical activity and exercise.. 1A A 9.8 (0.8) 
* The health professional and patient appraise whether advice to stay active, 
supervised physical exercise, or multidisciplinary treatment is needed.  
* If the patient is not able to initiate physical activity and exercises without 
help, then consider the possibility for referral to a physiotherapist for 
individually tailored graded physical exercise or strength training.  
* If psychosocial factors such as fear of movement[71, 80] or catastrophizing 
cognitions[70] underlie a disabled, sedentary lifestyle, then consider a 
multidisciplinary intervention including cognitive-behavioral therapy. 
   
5. If indicated, the patient should receive orthotics. 1A A 8.6 (0.9) 
* If a patient has pain during activities of daily living, which impedes 
functioning, orthotics (such as splints, braces, gloves, sleeves, insoles, and 
shoes), daily living aids (such as a tin opener), an assistive device (such as a 
cane or rollator), or ergonomic adaptation (at home, workplace) can be 
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offered. If the patients wants to use this assistive support, then consider 
referral to the occupational therapist, who can proceed with several actions: 
offer education about appropriate ways to use joints and ergonomic 
principles, appraise the need for the use of an orthotic or assistive device, 
give advice about how to acquire it, fit the customized aid to the patient, offer 
training in the use of it, refer to the appropriate specialist who will do this, 
e.g., orthopedic shoemaker. 
6. If indicated, the patient should receive psychological or social 
interventions. 
1A A 9.5 (0.6) 
* If there are indications that social variables or psychological factors 
interfere with effective pain management and functional status, then consider 
(depending on the severity) providing basic social and psychological 
management support or referral to a psychologist, social worker, self-
management support program, CBT, or multidisciplinary treatment.  
* If psychopathology (e.g., depression and anxiety) is present, discuss 
treatment options with the patient and the patient’s primary care physician. 
   
7. If indicated, the patient should receive sleep interventions. 1B B 8.4 (1.1) 
* If sleep disturbance is reported, inquire about causes (e.g., pain, persistent 
worrying, poor sleep habits) and offer basic education about good sleep 
hygiene practices.  
* If sleep remains (severely) disturbed refer to a therapist or program aimed 
at restoring sleep, or to a specialized sleep clinic.  
   
8. If indicated, the patient should receive weight management. 1A A 9.1 (1.0) 
* If the patient is obese, explain to the patient that obesity can contribute to 
pain and disability. Discuss accessible weight management options with the 
patient or signpost appropriate specialized weight management support; e.g., 
dietician, psychologist, community lifestyle services, or bariatric 
clinic/surgery. 
   
9. If indicated, the patient should receive pharmacological and joint-specific 
pain treatment according to recent recommendations. 
See [16, 17, 24-29] 9.5 (0.8) 
* Ask about the patient’s existing use of prescribed and over the counter pain 
relief including homeopathic remedies and consider if the frequency of use is 
safe (not over dosing) and appropriately regular. Ask or refer for further 
specialist or medical advice if there are concerns or if additional 
pharmacological treatment may be indicated.  
  
10. If indicated, the patient should receive multidisciplinary treatment. 4 D 8.8 (1.1) 
* If more than one treatment option is indicated, e.g. to treat psychological 
distress in combination with a sedentary lifestyle, and if monotherapy failed, 
consider a multidisciplinary intervention. 
   
Notes.  
‘Level of evidence’ and ‘Strength of recommendation’ for treatment modalities refer to specific diseases in which 
uniform positive effects on pain (excluding studies with ‘very low’ quality of evidence) were observed (tables 1 and 2). 
Overarching principles and recommendations regarding assessment are based on expert opinion.  
Level of evidence: 1A, from meta-analysis of randomized controlled trials; 1B, from at least one randomized controlled 
trial; 2A, from at least one controlled study without randomization; 2B, from at least one other type of quasi-
experimental study; 3, from descriptive studies, such as comparative studies, correlation studies or case–control 
studies; 4, from expert committee reports or opinions and/or clinical experience of respected authorities. 
Strength of recommendations is a combination of the information from the systematic literature review and expert 
opinion: A Category I evidence; B Category II evidence or extrapolated recommendations from category I evidence; C 
Category III evidence or extrapolated recommendation from category I or II evidence; D Category IV evidence or 
extrapolated recommendation from category II or III evidence.[22] 
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Level of agreement by the task force on a scale from 0 to 10. 
* Specific considerations regarding application of recommendations that are indicated with and asterisk are based on 
expert opinion of the task force. 
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Box 1. Research agenda 
- To examine omissions in knowledge such as effects of treatment options on pain in psoriatic 
arthritis, the effects of sleep interventions on pain in IA and OA, and pain as an outcome measures in 
studies of assistive devices such as a cane or rollator in more diseases than OA of the knee alone. 
- To examine in meta-analyses the effects of multidisciplinary treatment on pain.  
- To improve the methodological quality of treatment outcome studies. 
- To conduct an analysis examining effect sizes for more specific treatment modalities that are now 
merged into comprehensive treatment packages. 
- To examine moderators of treatment effects (e.g. in which patient subgroups each specific treatment 
option causes a reduction of pain). 
- To examine mediators of outcome, that is, how pain treatments work in IA and OA. 
- To examine the effects on pain of minimal interventions such as advice during a consultation, use of 
brochures, and e-health psychoeducation. 
- To examine whether combined pharmacological and non-pharmacological pain management is 
more effective than monotherapy. 
- To contribute to personalized medicine by analyzing customized pain treatments; e.g., using 
replicated single case experimental designs with idiosyncratic outcome measures. 
- To examine in which way health care could best be organized to be able to provide the best 
possible and knowledgeable pain management support for people with IA and OA. 
 
 
